Company intelligence / Profile preview
Pharma Foods International
- Ownership
- Private
- Employees
- ~670
- Development stage
- Other
Overview
Pharma Foods International has successfully commercialized several functional food ingredients with clinical evidence supporting their efficacy in areas like stress reduction (PharmaGABA®), bone health (Bonepep®, iHA®, Tamagosamin), hair growth stimulation (HGP®, Newmo), and more. The company’s antibody drug programs are at the research/preclinical stage with ongoing collaborations for further development.
- Therapeutic areas
- PsychiatryDermatologyEndocrinologyOncologyImmunologyRheumatology
- Modalities
- AntibodyPeptidesSmall moleculeRecombinant protein
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Pharma Foods International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pharma Foods International.